PROCEPT BioRobotics

Senior Aquablation Sales Representative - Upstate, NY

Buffalo, New York, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical DevicesIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate a strong sales background, with experience in medical device sales preferred. They should also have a proven ability to build relationships with key stakeholders and effectively communicate complex technical information.

Responsibilities

The Senior Aquablation Sales Representative will be responsible for launching the Aquabeam Robotic System in a defined territory, meeting or exceeding quarterly sales quotas, developing territory plans, providing monthly forecasts, communicating the system's value proposition, collaborating with hospital staff and surgeons, developing Aquablation plans for surgical teams, driving system utilization, expanding the user base, converting leads, delivering training, driving sales through new product introductions, and qualifying accounts to adopt the AquaBeam system.

Skills

Sales
Account Management
Lead Generation
Training
Communication
Collaboration
Forecasting
Presentation
Solution Selling
Business Development

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Key Metrics

Redwood City, CaliforniaHeadquarters
2009Year Founded
$319.1MTotal Funding
IPOCompany Stage
Robotics & Automation, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Parental Leave
Paid Holidays
Wellness Program
Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.
$175 million public stock offering could lead to shareholder dilution.
Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.
Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.
PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.
Global urology devices market projected to grow at 6.9% CAGR until 2030.
FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI